MedTruth

Bayer AG has been ordered by a jury in Missouri to pay $1.56 billion to four plaintiffs who claim they developed cancer because of exposure to Roundup weedkiller, a brand Bayer acquired when it purchased Monsanto in 2018. The Nov.

A U.S. appeals court recently ruled that California lacks the authority to enforce a regulation mandating cancer warnings on glyphosate, the main active compound in Monsanto's widely used herbicide Roundup, which was acquired by Bayer in 2018. The Ninth Circuit ruled Nov. 7 that the most recent warning issued by the state of California perpetuates the assertion that the chemical is hazardous, a claim deemed "at best disputed," Law360 reported.

The pharmacy chain Rite Aid is facing a new issue in its Chapter 11 Bankruptcy proceedings as the U.S. Department of Justice (DOJ) has announced intentions to defy the embattled company’s date to bar new claims in the proceedings. The chain, which declared bankruptcy amid a slew of legal claims of unlawful opioid prescription fulfillment, claims that the DOJ’s request could irrevocably cripple the company and prevent it from restructuring successfully.

Pharmaceutical company Eli Lilly is seeking to dismiss a lawsuit filed by a user of its diabetes drug, Mounjaro, who claims she developed severe stomach issues and that there should have been a warning about the risk of those side effects on the drug’s warning label. In a motion filed Oct. 30, Eli Lilly & Co. said that the lawsuit brought by Jaclyn Bjorklund should be tossed because there is, in fact, clear messaging about the risks on the label.

After losing three consecutive recent Roundup weedkiller trials, Bayer AG has filed a motion to have the second of those three decisions overturned because the trial judge improperly provided feedback to a Pennsylvania state court jury in Philadelphia that returned a $175 million jury verdict on Oct. 27 for Ernest Caranci, a retired restaurant owner who claims to have used the controversial weedkiller on a weekly basis for over 25 years. In the motion filed Nov.

A jury in California returned a plaintiff verdict for a man who claimed he developed cancer because of exposure to Monsanto’s Roundup weedkiller. The Oct. 31 verdict ordered Monsanto’s owner, Bayer AG, to pay Mike Dennis $332 million, NBC San Diego reported. After winning at trial in nine consecutive Roundup cases in 2022 and 2023, Bayer has now lost three straight cases, with each recent plaintiff verdict returned in October.

As more and more veterans impacted by the water contamination of Camp Lejeune sign on to claim benefits, the question of verdict rewards is raised. One of the main questions associated with these potential payouts is whether a verdict reward will impact a veteran receiving benefits from the Department of Veterans Affairs.

An 83-year-old resident of Philadelphia was awarded $175 million by a jury who found that the maker of Roundup weedkiller was liable for his cancer. The verdict in favor of plaintiff Ernest Caranci, announced Oct. 27, was delivered in a Philadelphia Common Pleas Court and marks the second consecutive trial loss for Bayer-owned Monsanto in recent days. On Oct.

The attorney general of Wisconsin has joined the attorneys general of 25 other states in a lawsuit addressed at the FDA over deficiencies in pulse oximeter inaccuracies. According to the latest AG’s statement, these devices pose an undue risk of underdiagnosing or misdiagnosing individuals of color. Pulse oximeters are a medical device invented in the 1980s intended to measure the blood oxygen levels of a patient.

Indivior, the manufacturer of the opioid addiction drug Suboxone, has settled with more than 40 states and Washington D.C. over claims that the company has unfairly extended its monopoly on the life-saving drug, according to Consumer Notice. According to the lawsuit, Indivior undertook a series of actions that ensured that the company could maintain a monopoly of their drug Suboxone.